| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc06cad2b58bbfcc30e3c96a6eb6c926 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-136
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate |
2020-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_649e2453900668801e63b5c57c857260
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f61711d771752991ba9977da945ad04f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22839d4b46b6cc2c2fe1ae05395fbac0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bf1967589ac6c94f46e1e19d00d9db9 |
| publicationDate |
2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-202103691-A |
| titleOfInvention |
Oral use drug and use of treating or postponing oral potentially malignant disorder thereof |
| abstract |
The present invention provides an oral use drug including gentian violet or benzalkonium chloride, and its use for treating or postponing the oral potentially malignant disorder. |
| priorityDate |
2019-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |